Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06552234
Title Phase II Efficacy Study of Repotrectinib in Frail and/or Elderly Patients With ROS1-rearranged Advanced NSCLC (REPOROS)
Acronym REPOROS
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA

Facility Status City State Zip Country Details
CH Aix-en-Provence Aix-en-Provence Bouches Du Rhône France Details
AP-HM Marseille Bouches Du Rhône France Details
HIA Sainte Anne Toulon Var France Details
CHU Angers Angers France Details
CHU Bordeaux Bordeaux France Details
CHU Brest Brest France Details
Centre François Baclesse Caen France Details
CH Chambéry Chambéry France Details
Hôpitaux civils de Colmar Colmar France Details
CHI Créteil Créteil France Details
CHD Vendée La Roche-sur-Yon France Details
CHRU Lille Lille France Details
CHU Limoges Limoges France Details
Hospices Civils de Lyon Lyon France Details
CH Cornouaille Quimper France Details
CHU Rennes Rennes France Details
CHU Rouen Rouen France Details
Hôpital Foch Suresnes France Details
CHU Toulouse Toulouse France Details
Hôpitaux Nord-Ouest Villefranche-sur-Saône France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field